Financial Survey: Li & Fung (OTCMKTS:LFUGY) versus Eisai (OTCMKTS:ESALY)

Profitability

This table compares Li & Fung and Eisai’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Li & Fung N/A N/A N/A
Eisai 4.11% 3.86% 2.50%

Institutional and Insider Ownership

0.0% of Eisai shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk and Volatility

Li & Fung has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500. Comparatively, Eisai has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500.

Earnings & Valuation

This table compares Li & Fung and Eisai”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Li & Fung $12.70 billion 0.08 $35.14 million N/A N/A
Eisai $6.74 billion 2.62 $426.79 million $0.87 70.70

Eisai has lower revenue, but higher earnings than Li & Fung.

Summary

Eisai beats Li & Fung on 6 of the 8 factors compared between the two stocks.

About Li & Fung

(Get Free Report)

Li & Fung Limited, an investment holding company, engages in managing the supply chain for retailers and brands worldwide. The company operates through two segments, Services and Products. The Services segment provides supply chain solutions, including product design, raw materials procurement, production and quality control, warehouse management, and last-mile delivery to retail stores or end-consumers in footwear and apparel, fast-moving consumer goods, food and beverage, and healthcare industries. The Products segment is involved in the onshore wholesale business. The company also engages in the distribution of fireworks. In addition, the company provides design and marketing, export trading, transportation, sample production, management and consultancy, sourcing, management support, commission agent, logistics, trade-related credit, accounting, freight forwarding, packaging, storage and warehousing, and customs brokerage services. Further, it designs, sources, and delivers apparel, accessories, and household items. The company serves specialty stores, department stores, big box retailers, e-commerce companies, hypermarkets, off-price retailers, and clubs. It operates through a network of approximately 230 offices and 270 distribution centers. Li & Fung Limited was founded in 1906 and is headquartered in Kowloon, Hong Kong.

About Eisai

(Get Free Report)

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Receive News & Ratings for Li & Fung Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Li & Fung and related companies with MarketBeat.com's FREE daily email newsletter.